| Regulation of MHC class II gene expression by the class II transactivator W Reith, S LeibundGut-Landmann, JM Waldburger Nature Reviews Immunology 5 (10), 793-806, 2005 | 571 | 2005 |
| Mini‐review: specificity and expression of CIITA, the master regulator of MHC class II genes S LeibundGut‐Landmann, JM Waldburger, M Krawczyk, LA Otten, T Suter, ... European journal of immunology 34 (6), 1513-1525, 2004 | 341 | 2004 |
| Maturation of dendritic cells is accompanied by rapid transcriptional silencing of class II transactivator (CIITA) expression S Landmann, A Mühlethaler-Mottet, L Bernasconi, T Suter, ... The Journal of experimental medicine 194 (4), 379, 2001 | 208 | 2001 |
| MHC class II expression is differentially regulated in plasmacytoid and conventional dendritic cells S LeibundGut-Landmann, JM Waldburger, CR e Sousa, H Acha-Orbea, ... Nature immunology 5 (9), 899-908, 2004 | 174 | 2004 |
| Selective abrogation of major histocompatibility complex class II expression on extrahematopoietic cells in mice lacking promoter IV of the class II transactivator gene JM Waldburger, T Suter, A Fontana, H Acha-Orbea, W Reith The Journal of experimental medicine 194 (4), 393, 2001 | 172 | 2001 |
| Rituximab in the treatment of antisynthetase syndrome L Brulhart, JM Waldburger, C Gabay Annals of the rheumatic diseases 65 (7), 974-975, 2006 | 146 | 2006 |
| Acetylcholine regulation of synoviocyte cytokine expression by the α7 nicotinic receptor JM Waldburger, DL Boyle, VA Pavlov, KJ Tracey, GS Firestein Arthritis & Rheumatism: Official Journal of the American College of …, 2008 | 122 | 2008 |
| STIM1 juxtaposes ER to phagosomes, generating Ca2+ hotspots that boost phagocytosis P Nunes, D Cornut, V Bochet, U Hasler, M Oh-Hora, JM Waldburger, ... Current Biology 22 (21), 1990-1997, 2012 | 111 | 2012 |
| Lessons from bare lymphocyte syndrome: molecular mechanisms regulating MHC class II expression. JM Waldburger, K Masternak, A Muhlethaler-Mottet, J Villard, M Peretti, ... Immunological reviews 178 (1), 2000 | 104 | 2000 |
| Residual MHC class II expression on mature dendritic cells and activated B cells in RFX5-deficient mice BE Clausen, JM Waldburger, F Schwenk, E Barras, B Mach, K Rajewsky, ... Immunity 8 (2), 143-155, 1998 | 86 | 1998 |
| Garden of therapeutic delights: new targets in rheumatic diseases JM Waldburger, GS Firestein Arthritis research & therapy 11, 1-11, 2009 | 67 | 2009 |
| Regulation of peripheral inflammation by the central nervous system JM Waldburger, GS Firestein Current rheumatology reports 12, 370-378, 2010 | 64 | 2010 |
| Ag-presenting CpG-activated pDCs prime Th17 cells that induce tumor regression L Guéry, J Dubrot, C Lippens, D Brighouse, P Malinge, M Irla, C Pot, ... Cancer research 74 (22), 6430-6440, 2014 | 58 | 2014 |
| Rheumatoid arthritis: B. Epidemiology, pathology, and pathogenesis JM Waldburger, GS Firestein Klippel, J. Stone J, Crofford L, White P. Primer on The Rheumatic Disease …, 2008 | 44 | 2008 |
| Promoter IV of the class II transactivator gene is essential for positive selection of CD4+ T cells JM Waldburger, S Rossi, GA Hollander, HR Rodewald, W Reith, ... Blood, The Journal of the American Society of Hematology 101 (9), 3550-3559, 2003 | 43 | 2003 |
| Spinal p38 MAP kinase regulates peripheral cholinergic outflow JM Waldburger, DL Boyle, M Edgar, LS Sorkin, YA Levine, VA Pavlov, ... Arthritis and rheumatism 58 (9), 2919, 2008 | 40 | 2008 |
| Efficacy of B cell depletion in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor α agents: an open-label observational study L Brulhart, A Ciurea, A Finckh, A Notter, JM Waldburger, D Kyburz, ... Annals of the rheumatic diseases 65 (9), 1255-1257, 2006 | 30 | 2006 |
| Intra-articular bioactivity of a p38 MAPK inhibitor and development of an extended-release system J Pradal, MF Zuluaga, P Maudens, JM Waldburger, CA Seemayer, ... European Journal of Pharmaceutics and Biopharmaceutics 93, 110-117, 2015 | 26 | 2015 |
| Long‐term amelioration of established collagen‐induced arthritis achieved with short‐term therapy combining anti‐CD3 and anti–tumor necrosis factor treatments F Dépis, E Hatterer, C Lamacchia, JM Waldburger, C Gabay, W Reith, ... Arthritis & Rheumatism 64 (10), 3189-3198, 2012 | 17 | 2012 |
| Autoimmunity and inflammation are independent of class II transactivator type PIV–dependent class II major histocompatibility complex expression in peripheral tissues during … JM Waldburger, G Palmer, C Seemayer, C Lamacchia, A Finckh, ... Arthritis & Rheumatism 63 (11), 3354-3363, 2011 | 10 | 2011 |
